Gender-related differences in pharmacological relapse prevention with flupenthixol decanoate in detoxified alcoholics.

Wiesbeck, G A; Weijers, H-G; Wodarz, N; Lesch, O M; Glaser, T; Boening, J

Wiesbeck, G A; Weijers, H-G; Wodarz, N; Lesch, O M; Glaser, T; Boening, J.

Affiliation

Wiesbeck GA; Department of Psychiatry, University of Wüerzburg, Wüerzburg, Füechsleinstr, 15, D-97080, Wüerzburg, Germany. gerhard.wiesbeck@pukbasel.ch

Arch Womens Ment Health ; 6(4): 259-62, 2003 Nov.

Article in En | MEDLINE | ID: mdl-14628178

Subject(s)

Alcoholism/drug therapy; Dopamine Antagonists/therapeutic use; Flupenthixol/therapeutic use; Adult; Alcoholism/prevention & control; Double-Blind Method; Female; Humans; Male; Middle Aged; Secondary Prevention; Sex Factors; Treatment Outcome; Women's Health

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dopamine Antagonists / Alcoholism / Flupenthixol Type of study: Clinical_trials Aspects: Determinantes_sociais_saude Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Arch Womens Ment Health Journal subject: PSICOLOGIA / SAUDE DA MULHER Year: 2003 Document type: Article Affiliation country: Germany Country of publication: Austria

Search on Google

Add to My VHL

XML

PubMed Links